Cargando…

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

Detalles Bibliográficos
Autores principales:	Li, Heng, Yu, Gan, Shi, Runlin, Lang, Bin, Chen, Xianguo, Xia, Ding, Xiao, Haibing, Guo, Xiaolin, Guan, Wei, Ye, Zhangqun, Xiao, Wei, Xu, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336090/ https://www.ncbi.nlm.nih.gov/pubmed/36068567 http://dx.doi.org/10.1186/s12943-022-01614-9

Ejemplares similares

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence
por: Xiao, Wei, et al.
Publicado: (2014)

A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer
por: Zhou, Hui, et al.
Publicado: (2015)

miR‐490‐5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA
por: Chen, Ke, et al.
Publicado: (2015)

MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer
por: Xiao, Haibing, et al.
Publicado: (2022)

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer
por: Shindo, Tetsuya, et al.
Publicado: (2018)

lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
por: Yu, Gan, et al.
Publicado: (2019)

DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer
por: Xu, Kai, et al.
Publicado: (2020)

MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44
por: Yu, Gan, et al.
Publicado: (2014)

Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
por: Ye, Rui, et al.
Publicado: (2017)

LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
por: Xiao, Haibing, et al.
Publicado: (2015)

MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2015)

Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2019)

Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR‐1270 inhibition
por: Yuan, Wenbo, et al.
Publicado: (2019)

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
por: Bissey, Pierre-Antoine, et al.
Publicado: (2020)

Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion
por: Ge, Lan, et al.
Publicado: (2021)

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011)

Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment
por: Thy, Sophia, et al.
Publicado: (2021)

Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo
por: Yang, Tao, et al.
Publicado: (2015)

LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray
por: Yu, Gan, et al.
Publicado: (2012)

Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma
por: Hu, Yuliang, et al.
Publicado: (2018)

Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
por: Wang, Lu Qian, et al.
Publicado: (2014)

MiR-34a in Age and Tissue Related Radio-Sensitivity and Serum miR-34a as a Novel Indicator of Radiation Injury
por: Liu, Cong, et al.
Publicado: (2011)

miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
por: Yang, Shiying, et al.
Publicado: (2020)

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2017)

CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer
por: Zeng, Jin, et al.
Publicado: (2021)

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Guancial, Elizabeth A., et al.
Publicado: (2016)

Regulation of glucose metabolism by p62/SQSTM1 through HIF1α
por: Chen, Ke, et al.
Publicado: (2016)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway
por: Jiang, Kehua, et al.
Publicado: (2018)

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
por: Dou, Dongwei, et al.
Publicado: (2019)

Small molecule targeting miR-34a for cancer therapy
por: Xiao, Zhangang, et al.
Publicado: (2015)

Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2
por: Liu, Jingyu, et al.
Publicado: (2016)

MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin
por: Jiang, Fangfang, et al.
Publicado: (2014)

Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
por: Ebner, Olivia A., et al.
Publicado: (2014)

Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
por: Fu, Yunfeng, et al.
Publicado: (2018)

miR-34a expression in human breast cancer is associated with drug resistance
por: Li, Zhi-Hua, et al.
Publicado: (2017)

Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells
por: Zheng, Hong, et al.
Publicado: (2020)

miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness
por: Zhang, Qing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_93hqihf98p237jral4idfi3kir